Grammati Sarri

Vice President, Evidence, Value, Access, and Health Policy

Grammati Sarri is Vice President, Evidence, Value, Access, and Health Policy at Cytel. Grammati is a dedicated health policy professional with a strong background in public health, data analysis and policy development from her previous roles in academia, National Institute for Health and Care Excellence, international consultancies, and clinical research organizations. Grammati is passionate about connecting data and methods to patient outcomes and developing innovative solutions that can bridge research and implementation by improving healthcare access and equity, including improving women’s health.

At Cytel, Grammati leads a group of specialists in public health policy, health equity, and value-based healthcare, bringing health economics and outcomes research activities closer to evidence-based policymaking. Grammati also leads Cytel’s EU JCA Taskforce and holds senior positions in international organizations (ISPE, ISPOR, EU-funded AI trial).

Grammati Sarri

Related Articles

Women’s Health Is Society’s Wealth: Unlocking Economic Value When Bridging the Gender Health Gap
Blog
October 29, 2025
Women’s Health Is Society’s Wealth: Unlocking Economic Value When Bridging the Gender Health Gap
Read More
Advancing Equity in Health Technology Assessment: Lessons from CAR T-Cell Therapies
Blog
April 22, 2025
Advancing Equity in Health Technology Assessment: Lessons from CAR T-Cell Therapies
Read More
Real-Life Data-Sharing and EU Joint Clinical Assessments: Is Closing this Chasm a Mission Impossible?
Blog
July 14, 2023
Real-Life Data-Sharing and EU Joint Clinical Assessments: Is Closing this Chasm a Mission Impossible?
Read More
Mind the Health Gap: Is It Time to Reliably Measure the Impact of Health Inequity in Product Development and Assessment? Yes, It Is.
Blog
October 20, 2023
Mind the Health Gap: Is It Time to Reliably Measure the Impact of Health Inequity in Product Development and Assessment? Yes, It Is.
Read More